Title : Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives.

Pub. Date : 2006

PMID : 16475928






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Blockers of Kir6.2/SUR1 channels, e.g. glibenclamide and repaglinide stimulate release of insulin and are used for treatment of type 2 diabetes. repaglinide ATP binding cassette subfamily C member 8 Homo sapiens